Assignee
BIONOR IMMUNO AS
NO·13 granted patents·3 pending applications·47 citations·filing 2000–2016
Top patents by PatentIndex Score
16 records- 0189US6706859B1HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIVBIONOR IMMUNO AS·Filed 2000·Granted Mar 16, 2004·20 cites·6 claims
- 0282US7612168B2Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIVBIONOR IMMUNO AS·Filed 2005·Granted Nov 3, 2009·5 cites·15 claims
- 0381US7097971B2HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kitBIONOR IMMUNO AS·Filed 2001·Granted Aug 29, 2006·10 cites·9 claims
- 0480US7009037B2Modified HIV-1gag p17 peptide and immunogenic compositionBIONOR IMMUNO AS·Filed 2001·Granted Mar 7, 2006·11 cites·7 claims
- 0568US10124059B2Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopesBIONOR IMMUNO AS·Filed 2016·Granted Nov 13, 2018·1 cites·12 claims
- 0665US7709003B2Method of producing an HIV-1 immune responseBIONOR IMMUNO AS·Filed 2007·Granted May 4, 2010·0 cites·15 claims
- 0765US7709004B2Method of producing an HIV-1 immune responseBIONOR IMMUNO AS·Filed 2007·Granted May 4, 2010·0 cites·15 claims
- 0862US7311915B2Method of producing an HIV-1 immune responseBIONOR IMMUNO AS·Filed 2003·Granted Dec 25, 2007·0 cites·15 claims
- 0943US10251949B2Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domainBIONOR IMMUNO AS·Filed 2015·Granted Apr 9, 2019·0 cites·11 claims
- 1039US2017112917A1Peptide scaffold designBIONOR IMMUNO AS·Filed 2016·Application pending·0 cites
- 1137US10335482B2Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimerBIONOR IMMUNO AS·Filed 2013·Granted Jul 2, 2019·0 cites·1 claims
- 1235US10501499B2Peptides derived from viral proteins for use as immunogens and dosage reactantsBIONOR IMMUNO AS·Filed 2013·Granted Dec 10, 2019·0 cites·9 claims
- 1332US10143737B2Method for the vaccination against HIVBIONOR IMMUNO AS·Filed 2015·Granted Dec 4, 2018·0 cites·22 claims
- 1431US10449245B2Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agentBIONOR IMMUNO AS·Filed 2015·Granted Oct 22, 2019·0 cites·17 claims
- 1531US2017165321A1Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)BIONOR IMMUNO AS·Filed 2015·Application pending·0 cites
- 1628US2018140694A1Dosage regimen for hiv vaccineBIONOR IMMUNO AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIONOR IMMUNO AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →